NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma

When should androgen‑deprivation therapy be added to salvage radiotherapy after prostatectomy?

Androgen‑deprivation therapy (ADT) should be added to salvage radiotherapy (SRT) after radical prostatectomy when biochemical recurrence (BCR) is accompanied by high‑risk features—most guidelines and ...